| NewAmsterdam Pharma B.V.. (6/28/22). "Press Release: NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe". Naarden, Miami, FL & Florence. |
2022-06-28 |
| Biotalys N.V.. (6/21/22). "Press Release: Biotalys and Novozymes Enter into Partnership to Expand Opportunities for Evoca". Ghent & Copenhagen. |
2022-06-21 |
| Knauer Wissenschaftliche Geräte GmbH. (6/21/22). "Press Release: Knauer Wissenschaftliche Geräte Is Partnering with ModuVision". |
2022-06-21 |
| Galapagos N.V.. (6/21/22). "Press Release: Galapagos to Acquire CellPoint and AboundBio to Accelerate Access to Next-generation Cell Therapies". Mechelen, Leiden & Pittsburgh, PA. |
2022-06-21 |
| Genomatica, Inc.. (6/16/22). "Press Release: Geno and Unilever Launch $120m Venture to Scale Alternative to Palm Oil and Fossil Fuels". San Diego, CA & London. |
2022-06-16 |
| Gimv. (6/15/22). "Press Release: Gimv Strengthens Its Position in Life Sciences Venture Capital with the Creation of a New Dedicated Platform". Antwerp. |
2022-06-15 |
| High-Tech Gründerfonds Management GmbH. (6/14/22). "Press Release: Over €400 Million. New High-Tech Gründerfonds Seed Fund Exceeds Expectations". Bonn. |
2022-06-14 |
| Evotec SE. (6/14/22). "Press Release: Evotec Enters a Drug Discovery Collaboration with Janssen". Hamburg. |
2022-06-14 |
| ImCheck Therapeutics S.A.S.. (6/13/22). "Press Release: ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immuno |
2022-06-13 |
| CimCure. (6/21/22). "Press Release: Cancer Vaccine Biotech CimCure Raises € 5 Million in Seed Round Investment Led by Positron Ventures". |
2022-06-10 |
| Metrion Biosciences Ltd.. (6/9/22). "Press Release: Metrion Biosciences Appoints Dr Benedetta Montagnini as Head of European Business Development". Cambridge. |
2022-06-09 |
| Ziphius Vaccines N.V.. (6/9/22). "Press Release: Ziphius Vaccines and University of Antwerp Announce Collaboration Agreement for Optimized Delivery of saRNA-based Vaccines & Therapeutics". |
2022-06-09 |
| Forbion Capital Partners. (6/9/22). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund II at €470 Million". Naarden & Munich. |
2022-06-09 |
| Ariceum Therapeutics GmbH. (6/8/22). "Press Release: Ariceum Therapeutics Launches with EUR 25M Series A to Advance Lead Asset, Satoreotide, for the Treatment of Low- and High-Grade Neuroendocrine Cancers". Berlin. |
2022-06-08 |
| ImmunOs Therapeutics AG. (6/7/22). "Press Release: ImmunOs Therapeutics Raises $74 Million Series B Financing Round". Schlieren & Gaithersburg, MD. |
2022-06-07 |
| Vizgen Inc.. (6/3/22). "Press Release: Vizgen Announces $85.2 Million Series C Financing". Cambridge, MA. |
2022-06-03 |
| DSM N.V.. (6/2/22). "Press Release: DSM and Firmenich to Merge, Becoming the Leading Creation and Innovation Partner in Nutrition, Beauty and Well-being [NOT FOR RELEASE WHERE VIOLATION OF LAW]". Vienna. |
2022-06-02 |
| Proxygen GmbH. (6/2/22). "Press Release: Proxygen Announces Strategic Collaboration with Merck to Develop Molecular Glue Degraders". Vienna. |
2022-06-02 |
| Immatics N.V.. (6/2/22). "Press Release: Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs". Tübingen, Houston, TX & New York, NY. |
2022-06-02 |
| Immunic, Inc.. (6/2/22). "Press Release: Immunic, Inc. Reports Top-Line Data from Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Patients with Moderate-to-Severe Ulcerative Colitis and Provides Corporate Update". New York, NY. |
2022-06-02 |
| Minoryx Therapeutics S.L.. (5/31/22). "Press Release: Minoryx Raises €51 Million to Support Marketing Authorization Application and Launch Preparations for X-linked Adrenoleukodystrophy (X-ALD) therapy". Mataró, Barcelona. |
2022-05-31 |
| Eurofins Scientific SE. (5/31/22). "Press Release: Eurofins Enhances Its Clinical and BioPharma Service Offering in Japan with Immune Repertoire Analysis Technology Through the Acquisition of Repertoire Genesis Inc.". Luxembourg. |
2022-05-31 |
| BRAIN Biotech AG. (5/30/22). "Press Release: Ongoing Dynamic Sales Development and Rising Profitability, 6M Reporting". Zwingenberg. |
2022-05-30 |
| CureVac N.V.. (5/25/22). "Press Release: CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development". Tübingen & Ghent. |
2022-05-25 |
| Alithea Genomics. (5/24/22). "Press Release: Alithea Genomics Raises CHF 1 Million in Seed Financing Round led by Novalis Biotech". Lausanne. |
2022-05-24 |
| NLC Ventures Netherlands B.V.. (5/23/22). "Press Release: Allergios Closes Their Latest Round of Seed Financing". |
2022-05-23 |
| Synexa Life Sciences B.V.. (5/19/22). "Press Release: Synexa Life Sciences Acquires Finnish CRO Syrinx Bioanalytics to Expand Bioanalysis Capabilities". Leiden. |
2022-05-19 |
| FlandersBio. (5/18/22). "Press Release: Flanders.Bio Appoints CEO and COO in Newly Created Role". |
2022-05-18 |
| Synexa Life Sciences B.V.. (5/18/22). "Press Release: Synexa Life Sciences Announces Strategic Growth Plans and Strengthening of Its Executive Team". Leiden. |
2022-05-18 |
| Avantium N.V.. (5/17/22). "Press Release: Avantium Awarded €3 Million EU Grant to Demonstrate the Electrochemical Conversion of CO2 to Consumer Products". Amsterdam. |
2022-05-17 |
| Sofinnova Partners. (5/16/22). "Press Release: Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences". New York, NY & Paris. |
2022-05-16 |
| Valneva S.E.. (5/16/22). "Press Release: Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 Vaccine Purchase Agreement". Saint-Herblain. |
2022-05-16 |
| Domain Therapeutics S.A.. (5/12/22). "Press Release: Domain Therapeutics Raises $42m Series A Financing to Accelerate Clinical Development of Its Best-in-Class and First-in-Class Immuno-oncology Programs". Strasbourg & Montréal, ON. |
2022-05-12 |
| Bone Therapeutics S.A.. (5/12/22). "Press Release: Bone Therapeutics Enters into Exclusive Reverse Merger Discussions with Medsenic". Mont-Saint-Guibert. |
2022-05-12 |
| Qiagen N.V.. (5/11/22). "Press Release: Qiagen Acquires Majority Stake in Enzymes Provider BLIRT S.A.". Hilden & Germantown, MD. |
2022-05-11 |
| NeoGenomics, Inc.. (5/9/22). "Press Release: NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary". Ft. Myers, FL. |
2022-05-09 |
| European Spatial Biology Center (ESBC). (5/4/22). "Press Release: The European Spatial Biology Center (ESBC). State-of-the-Art Spatial Biology Services Enabled at Scale in Leuven". |
2022-05-04 |
| Tubulis GmbH. (5/3/22). "Press Release: Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies". Munich. |
2022-05-03 |
| Hemispherian AS. (5/3/22). "Press Release: Hemispherian Raises Seed Funding for Novel Cancer Therapeutics". Oslo. |
2022-05-03 |
| Byondis B.V.. (5/3/22). "Press Release: Byondis and Medac Enter into License and Collaboration and Supply Agreements for Anti-HER2 ADC Trastuzumab Duocarmazine (SYD985)". Nijmegen & Wedel. |
2022-05-03 |
| Bone Therapeutics S.A.. (4/29/22). "Press Release: Bone Therapeutics Announces 2021 Full Year Results". Mont-Saint-Guibert. |
2022-04-29 |
| Quell Therapeutics Ltd.. (4/27/22). "Press Release: Quell Therapeutics and Cellistic Enter a Strategic Collaboration to Develop an iPSC-derived Allogeneic T-regulatory (Treg) Cell Therapy Platform". London & Gosselies. |
2022-04-27 |
| Toulouse White Biotech (TWB). (4/27/22). "Press Release: TWB Expands Its Industrial Biotechnology Solutions by Partnering with Processium and Syngulon". London & Gosselies. |
2022-04-27 |
| Symeres. (4/26/22). "Press Release: Symeres Acquires Organix Inc., Adding Lipids Expertise and a Strategic Foothold in the US". Nijmegen. |
2022-04-26 |
| Mainz Biomed N.V.. (4/26/22). "Press Release: Mainz Biomed Appoints Darin Leigh as Chief Commercial Officer". Berkeley, CA & Mainz. |
2022-04-26 |
| ProteoNic. (4/26/22). "Press Release: ProteoNic and NecstGen Establish Partnership to Improve Viral Vector Manufacturing Efficiency for Gene Therapies". Leiden. |
2022-04-26 |
| Sygnature Discovery Ltd.. (4/26/22). "Press Release: Sygnature Discovery Acquires Peak Proteins, to Strengthen Its Drug Discovery Capabilities". Nottingham. |
2022-04-26 |
| Euronext N.V.. (4/25/22). "Press Release: BenevolentAI Lists on Euronext Amsterdam. Listed Following Business Combination with Odyssey Acquisition S.A.". Amsterdam. |
2022-04-25 |
| BenevolentAI. (4/25/22). "Press Release: BenevolentAI Begins Trading On Euronext Amsterdam". London. |
2022-04-25 |
| Stentit B.V.. (4/25/22). "Press Release: MedTech Company Stentit Raises €1.8 Million in Seed Round". Eindhoven. |
2022-04-25 |
| CureVac N.V.. (4/21/22). "Press Release: CureVac and GSK’s Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study". Tübingen & Boston, MA. |
2022-04-21 |
| NLC Ventures Netherlands B.V.. (4/20/22). "Press Release: Charles River Laboratories and NLC Collaborate". |
2022-04-20 |
| VIB, Flanders Interuniversity Institute of Biotechnology. (4/20/22). "Press Release: Christine Durinx Joins VIB as Co-Managing Director". |
2022-04-20 |
| Affimed N.V.. (4/13/22). "Press Release: Affimed Announces Pricing of Upsized $90 Million Public Offering of Common Shares". Heidelberg. |
2022-04-13 |
| Monkeys not Donkeys. (4/13/22). "Press Release: Quality by Design (QbD) Acquires Marketing & Communication Agency ‘Monkeys not Donkeys’ to Strengthen Its Services within the Life Science Industry". Wilrijk & Ghent. |
2022-04-13 |
| Affimed N.V.. (4/12/22). "Press Release: Affimed Announces Proposed Public Offering of Common Shares". Heidelberg. |
2022-04-12 |
| Bone Therapeutics S.A.. (4/12/22). "Press Release: Bone Therapeutics Secures EUR 5 Million Financing [Not for US, AU, CA, et al.]". Mont-Saint-Guibert. |
2022-04-12 |
| CureVac N.V.. (4/11/22). "Press Release: CureVac and GSK Enter into Pandemic Preparedness Contract with German Government". Tübingen & Boston, MA. |
2022-04-11 |
| Affimed N.V.. (4/10/22). "Press Release: Affimed Presents Updated Clinical Data from Phase 1/2 Study of AFM13 Precomplexed with Cord Blood-Derived NK Cells at AACR Annual Meeting". Heidelberg. |
2022-04-10 |
| Affimed N.V.. (4/8/22). "Press Release: Affimed Presents Findings from the Dose-escalation Phase of the First-in-human Study of AFM24 in Patients with EGFR-positive Solid Tumors". Heidelberg. |
2022-04-08 |
| Labster ApS. (4/4/22). "Press Release: Labster Secures $47M in New Funding Tranche to Expand Global Opportunities for Virtual Science Laboratory Simulations". Copenhagen & Boston, MA. |
2022-04-04 |
| AXA Investment Managers. (4/4/22). "Press Release: AXA IM Alts Launches $500 Million Private Equity Healthcare Strategy alongside Two Senior Appointments". |
2022-04-04 |
| Forbion Capital Partners. (3/31/22). "Press Release: Forbion Appoints Both Dr Ton Logtenberg and Dr Michael Hayden as Venture Partners". Naarden. |
2022-03-31 |
| Affimed N.V.. (3/31/22). "Press Release: Affimed Reports 2021 Financial Results and Highlights Recent Operational Progress". Heidelberg. |
2022-03-31 |
| V-Bio Ventures. (3/31/22). "Press Release: V-Bio Ventures Raises EUR 110 Million for its Second Fund and Expands Team". Ghent. |
2022-03-31 |
| Oxford Science Enterprises. (3/31/22). "Press Release: Oxford Science Enterprises Strengthens Investment Teams with Two New Appointments". |
2022-03-31 |
| Avantium N.V.. (3/31/22). "Press Release: Avantium Reaches Financial Close for its FDCA Flagship Plant". Amsterdam. |
2022-03-31 |
| miDiagnostics N.V.. (3/30/22). "Press Release: miDiagnostics Welcomes Nicolas De Clercq as Its New Chief Financial Officer". Leuven. |
2022-03-30 |
| CureVac N.V.. (3/30/22). "Press Release: CureVac and GSK Start Clinical Development of Second-generation COVID-19 Vaccine Candidate, CV2CoV". Tübingen & Boston, MA. |
2022-03-30 |
| Kadans Science Partner. (3/30/22). "Press Release: Europe’s Largest Commercial Lab Building to Be Built at Canary Wharf, London". |
2022-03-30 |
| Bone Therapeutics S.A.. (3/29/22). "Press Release: Bone Therapeutics to Strategically Focus on Lead Cell Therapy Product ALLOB". Mont-Saint-Guibert. |
2022-03-29 |
| Core Biogenesis S.A.S.. (3/29/22). "Press Release: Core Biogenesis Raises €10M from XAnge and Blue Horizon Ventures to Accelerate Treatment of Cancer and Neurodegenerative Diseases". |
2022-03-29 |
| Argenx SE. (3/29/22). "Press Release: Argenx Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs". Breda. |
2022-03-29 |
| XAnge (Alexis du Peloux). (3/29/22). "Press Release (Blog Post): Core Biogenesis – When a Deeptech Goes Faster than Eexpected, Let’s Speed Up!". |
2022-03-29 |
| ImmunoPrecise Antibodies Ltd.. (3/29/22). "Press Release: IPA Announces Agreement to Acquire BioStrand BV". Victoria, BC. |
2022-03-29 |
| Diadem S.p.A.. (3/28/22). "Press Release: Diadem Announces First Closing of €10 Million Equity Financing for Its AlzoSure Predict Prognostic Blood Test for Alzheimer’s Disease". Milan. |
2022-03-28 |
| Argenx SE. (3/23/22). "Press Release: Argenx Raises $700 Million in Gross Proceeds in a Global Offering". Breda. |
2022-03-23 |
| Qbic. (3/17/22). "Press Release: Qbic Establishes Third Fund. Qbic Announces First Close of New Fund at € 49 Million to Invest in Spin-offs from World-class Knowledge Partners". St-Denijs-Westrem. |
2022-03-17 |
| Gilde Healthcare Partners. (3/16/22). "Press Release: Gilde Healthcare Raises more than €500 Million for Private Equity Investments in European Healthcare Companies". Utrecht. |
2022-03-16 |
| Precirix N.V.. (3/16/22). "Press Release: Precirix Raises EUR 80m in Series B to Advance Its Pipeline of Precision Radiopharmaceuticals". Brussels. |
2022-03-16 |
| Ryvu Therapeutics S.A.. (3/15/22). "Press Release: Ryvu Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update". Krakow. |
2022-03-15 |
| Forbion Capital Partners. (3/14/22). "Press Release: Forbion Strengthens Its Team with the Appointments of Mathias Vinther and Vanessa Carle". Naarden. |
2022-03-14 |
| Scenic Biotech B.V.. (3/10/22). "Press Release: Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases". Amsterdam. |
2022-03-10 |
| Enzymicals AG. (3/8/22). "Press Release: Enzymicals AG Board of Supervisors Appoints New Management with Dr. Erik de Vries as CEO". Greifswald. |
2022-03-08 |
| Kurma Partners. (3/7/22). "Press Release: Kurma Partners Targets €250 Million for its First Growth Opportunities Fund". Paris. |
2022-03-07 |
| Enamine Ltd.. (3/7/22). "Press Release: Open Letter from Enamine Founder and CEO Dr. Andrey Tolmachov". |
2022-03-07 |
| European Invesmtent Bank (EIB). (3/7/22). "Press Release: Italy – EIB Provides €7.5 Million Loan for Research and Development of Diadem’s AlzoSure Predict Blood Test for Alzheimer’s disease". |
2022-03-07 |
| Ysios Capital. (3/4/22). "Press Release: Ysios Capital Strengthens Its Team with the Appointment of Thomas Harth as Principal
Thomas Harth". San Sebastián & Barcelona. |
2022-03-04 |
| AbbVie Inc.. (3/1/22). "Press Release: AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio". North Chicago, IL. |
2022-03-01 |
| CureVac N.V.. (3/1/22). "Press Release: CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer". Tübingen & Boston, MA. |
2022-03-01 |
| ECBF Management GmbH. (3/1/22). "Press Release: €34M to End Chick Culling. Impact Fund ECBF Invests In AgTech In Ovo". Luxembourg. |
2022-03-01 |
| EQT AB. (3/1/22). "Press Release: EQT Closes Acquisition of LSP and Introduces EQT Life Sciences". |
2022-03-01 |
| Ampersand Capital Partners. (3/1/22). "Press Release: BioEcho Life Sciences Receives Growth Equity Investment from Ampersand Capital Partners". Cologne. |
2022-03-01 |
| Celeris Therapeutics GmbH. (2/24/22). "Press Release: CelerisTx Appoints Pharmaceuticals Industry Leader Peter Ho, M.D., Ph.D., to the Board of Directors". Menlo Park, CA. |
2022-02-24 |
| Ncardia Services B.V.. (2/24/22). "Press Release: Ncardia Appoints Andy Holt as Chief Commercial Officer". Leiden. |
2022-02-24 |
| ECBF Management GmbH. (2/23/22). "Press Release: Growth Capital for Sustainable Transformation to a Bio-based Circular Economy. EU-initiated Impact Fund Oversubscribed with € 300 million". Luxembourg. |
2022-02-23 |
| Complement Therapeutics Ltd.. (2/23/22). "Press Release: Complement Therapeutics Ltd Raises EUR 5 Million Seed Financing by BGV and Forbion and Appoints Dr Rafiq Hasan as CEO". London. |
2022-02-23 |
| TargED Biopharmaceuticals B.V.. (2/22/22). "Press Release: TargED Biopharmaceuticals Raises EUR 39 Million in Series A Financing to Bring Groundbreaking Thrombolytic Treatment to Patients". Utrecht. |
2022-02-22 |
| SpliceBio S.L.. (2/16/22). "Press Release: SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline". Barcelona. |
2022-02-16 |
| Newton Biocapital. (2/15/22). "Press Release: Newton Biocapital Launches a New Fund with Initial Capital Commitments of EUR 50 Million and Target Size of EUR 150 Million". Brussels. |
2022-02-15 |
![[LSBNL] Life-Sciences-Benelux.com - The Benelux Life Sciences Web Portal](/images/basics/lsbnl-life-sciences-benelux-portal-logo-2019.png){kind=logo}
Date![Picture [iito] Fighting Customers 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-fighting-customers.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
